Expression of CD44v6 in colorectal cancer and its impact on chemosensitivity: Progression in research
10.3760/cma.j.issn.1673-4203.2018.12.016
- VernacularTitle:CD44v6在结直肠癌中的表达及其对化疗敏感性影响研究进展
- Author:
Xiaoping YANG
1
;
Liang ZHENG
;
Dan ZHANG
;
Jianxin GAN
;
Lanning YIN
;
Xichen WANG
;
Jiebin PAN
;
Zengxi YANG
Author Information
1. 730000,兰州大学第二医院普外六科
- Keywords:
Colorectal neoplasms;
Drug therapy,combination;
Drug resistance,neoplasms;
CD44v6
- From:
International Journal of Surgery
2018;45(12):854-858
- CountryChina
- Language:Chinese
-
Abstract:
Colorectal cancer is one of the most common malignant tumors,early diagnosis and treatment are the important factors affecting colorectal cancer's prognosis.It has been proved that colorectal cancer's diagnosis combined with biomolecular markers is non-invasive,economical and specific at the same time,biomarkers are valuable in predicting and monitoring the chemoresistance of colorectal cancer.This article mainly reviews the prediction of liver metastasis of colorectal cancer,drug resistance of postoperative chemotherapy in colorectal cancer and the monitoring of drug resistance in the course of chemotherapy by CD44v6.
